Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors
Top Cited Papers
- 3 August 2003
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 21 (9) , 1040-1046
- https://doi.org/10.1038/nbt856
Abstract
Characterizing the molecular diversity of the cell surface is critical for targeting gene therapy. Cell type-specific binding ligands can be used to target gene therapy vectors. However, targeting systems in which optimum eukaryotic vectors can be selected on the cells of interest are not available. Here, we introduce and validate a random adeno-associated virus (AAV) peptide library in which each virus particle displays a random peptide at the capsid surface. This library was generated in a three-step system that ensures encoding of displayed peptides by the packaged DNA. As proof-of-concept, we screened AAV-libraries on human coronary artery endothelial cells. We observed selection of particular peptide motifs. The selected peptides enhanced transduction in coronary endothelial cells but not in control nonendothelial cells. This vector targeting strategy has advantages over other combinatorial approaches such as phage display because selection occurs within the context of the capsid and may have a broad range of applications in biotechnology and medicine.Keywords
This publication has 52 references indexed in Scilit:
- Conjugate-Based Targeting of Recombinant Adeno-Associated Virus Type 2 Vectors by Using Avidin-Linked LigandsJournal of Virology, 2002
- Cell-Type-Specific Characteristics Modulate the Transduction Efficiency of Adeno-Associated Virus Type 2 and Restrain Infection of Endothelial CellsJournal of Virology, 2002
- Gene Therapy a Suspect in Leukemia-like DiseaseScience, 2002
- Insertional Mutagenesis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Generation of AAV2 Vectors Targeted to Alternative Cell-Surface ReceptorsHuman Gene Therapy, 2001
- Efficient and Selective AAV2-Mediated Gene Transfer Directed to Human Vascular Endothelial CellsMolecular Therapy, 2001
- Incorporation of Tumor-Targeting Peptides into Recombinant Adeno-associated Virus CapsidsMolecular Therapy, 2001
- Molecular Adaptors for Vascular-Targeted Adenoviral Gene DeliveryHuman Gene Therapy, 2000
- Targeting adenovirusGene Therapy, 2000
- Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2Gene Therapy, 1999
- Organ targeting In vivo using phage display peptide librariesNature, 1996